Clinical Trials Logo

Clinical Trial Summary

The objectives of this study are to establish the performance characteristics of the AC2 (APTIMA Combo 2) Assay on the PANTHER System for the sample types cleared for use on the TIGRIS and DTS (Direct Tube Sampling) Systems and to demonstrate the repeatability and reproducibility of the AC2 Assay on the PANTHER System.


Clinical Trial Description

The results of this protocol AC2PS-US11-001 (NCT01733069) are based on samples collected from protocol ACTPS-US10-001(NCT01358799).

The registration for NCT01358799 was withdrawn because the samples were not tested under protocol ACTPS-US10-001, instead they were tested under the protocol registered here AC2PS-US11-001 (NCT01733069). ;


Study Design

Observational Model: Cohort, Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


NCT number NCT01733069
Study type Observational
Source Gen-Probe, Incorporated
Contact
Status Completed
Phase N/A
Start date November 2010
Completion date February 2012

See also
  Status Clinical Trial Phase
Completed NCT03676816 - Self Sampling for Rapid Turnaround Testing in the Emergency Department N/A
Completed NCT00213018 - Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission Phase 2
Completed NCT00827970 - Randomized Population-Based Study on Chlamydia Trachomatis Screening N/A
Withdrawn NCT01358799 - Clinical Evaluation of the APTIMA® Assay for Chlamydia Trachomatis Using the PANTHER™ System N/A
Completed NCT00978848 - Non-Invasive Sexually Transmitted Disease Testing in Women Seeking Emergency Contraception or Urine Pregnancy Testing N/A
Completed NCT02391233 - Multimedia WORTH With Black Drug-Involved Women on Probation N/A
Completed NCT00973466 - Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients N/A
Completed NCT03071510 - Evaluation of the Atlas Genetics io® CTNG System
Recruiting NCT04446611 - Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes N/A
Completed NCT01329588 - Periodical Presumptive Treatment for the Control of Gonococcal Infections Among Sex Workers Phase 4
Not yet recruiting NCT06216964 - Time to Clearance of Chlamydia Trachomatis and Neisseria Gonorrhoeae RNA After Treatment: a Prospective Cohort Study N/A
Terminated NCT02795975 - Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples N/A
Completed NCT00213057 - Safety and Acceptability of Carraguard™ Among HIV-negative Couples in Thailand Phase 1
Completed NCT00207454 - Optimizing Strategies to Improve STD Partner Services Phase 1
Completed NCT00177437 - Home Screening for Chlamydia Surveillance Phase 3
Completed NCT02787109 - Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years Phase 1
Completed NCT01665690 - Washington State Community Expedited Partner Treatment (EPT) Trial Phase 4
Completed NCT02128620 - A Randomized Online Health Experiment for a Safer Youth Sexual Behaviour N/A
Completed NCT00618449 - Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger Phase 4
Recruiting NCT01661985 - Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced Phase 4